Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders

Serotonergic 5HT7 receptor compounds for treating ocular and CNS disorders

US Patent 6960579 · Granted Nov 1, 2005

Estimated economic value: $61,439,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Tris-substituted biguanide compounds and their uses2024
Prophylactic and/or therapeutic agent containing pyridylaminoacetic acid compoun2022
Branched polymeric biguanide compounds and their uses2021
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2018
Prostaglandin conjugates and derivatives for treating glaucoma and ocular hypert2017
Branched polymeric quaternary ammonium compounds and their uses2016
Polymeric quaternary ammonium compounds with vicinal hydroxy groups2013
Use of bradykinin and related B2R agonists to treat ocular hypertension and glau2012
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and g2012
Bradykinin receptor agonists and uses thereof to treat ocular hypertension and g2012
Use of non-peptidic bradykinin receptor agonists to treat ocular hypertension an2012
Hydroxyamino- and amino-substituted pyridine analogs for treating rho kinase-med2011